CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop

Hyung Joon Yim, Ji Hoon Kim, Jun Yong Park, Eileen L. Yoon, Hana Park, Jung Hyun Kwon, Dong Hyun Sinn, Sae Hwan Lee, Jeong-Hoon Lee, Hyun Woong Lee

Clin Mol Hepatol. 2020;26(4):411-429. Published online 2020 August 28 DOI: https://doi.org/10.3350/cmh.2020.0049

Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop

Hyung Joon Yim, Ji Hoon Kim, Jun Yong Park, Eileen L. Yoon, Hana Park, Jung Hyun Kwon, Dong Hyun Sinn, Sae Hwan Lee, Jeong-Hoon Lee, Hyun Woong Lee

Clinical and Molecular Hepatology. 2020;26(4):411-429

Link1

Link2 Link3

Current approaches for treating chronic hepatitis B: when to start, what to start with, and when to stop

Ting-Tsung Chang, Dong Jin Suh

Hepatology International. 2008;2(S1):19-27

Link1

Link2 Link3

The Yin and the Yang of Treatment for Chronic Hepatitis B—When to Start, When to Stop Nucleos(t)ide Analogue Therapy

Samuel Hall, Jessica Howell, Kumar Visvanathan, Alexander Thompson

Viruses. 2020;12(9):934

Link1

Clinical trials: when to start and when to stop

Edmund Hey

The Lancet. 2002;359(9316):1449

Link1 Link2

Direct markers of organ perfusion to guide fluid therapy: When to start, when to stop

G. Veenstra, C. Ince, E.C. Boerma

Best Practice & Research Clinical Anaesthesiology. 2014;28(3):217-226

Link1 Link2

Management of Favorable-Risk Patients With Metastatic Renal Cell Carcinoma: When to Start and When to Stop Targeted Therapy

Thomas Powles, Peter Albers

Clinical Genitourinary Cancer. 2012;10(4):213-218

Link1 Link2

When to start and when to stop primary prophylaxis in patients with severe haemophilia

J. Astermark

Haemophilia. 2003;9:32-37

Link1 Link2 Link3

When Do You Start and When Do You Stop Screening for Colon Cancer in Inflammatory Bowel Disease?

Millie D. Long, Bruce E. Sands

Clinical Gastroenterology and Hepatology. 2018;16(5):621-623

Link1 Link2

Locoregional therapy in hepatocellular carcinoma: when to start and when to stop and when to revisit

J.J.X. Lee, D.W.-M. Tai, S.P. Choo

ESMO Open. 2021;6(3):100129

Link1 Link2

Renal replacement therapy for AKI: When? How much? When to stop?

Stefano Romagnoli, William R. Clark, Zaccaria Ricci, Claudio Ronco

Best Practice & Research Clinical Anaesthesiology. 2017;31(3):371-385

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.